Q517--Contingency Hazardous Compounding Services VHA VISN 10 VA Medical Facilities

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 (VHA VISN 10) is soliciting contingency hazardous pharmaceutical compounding services through solicitation 36C25026Q0292, issued February 27, 2026. The contractor must be FDA 503A compliant and capable of compounding hazardous chemotherapy agents according to USP 797 and USP 800 standards, delivering compounds within 24 hours of order submission. Key requirements include supplying all drugs, IV tubing, and closed-system transfer devices, with pricing based on Average Wholesale Price (AWP) plus or minus a discount percentage, and separate per diem, mixing, and STAT order fees. The evaluation criteria include administrative compliance, price (assessed using net present value at 6% discount rate), technical capability and FDA compliance certification, delivery timeline and contingency planning, and past performance. Vendors must submit quotations electronically to Joshua.Kovar@VA.gov by March 20, 2026, at 1:30 PM EST, with a questions and answers period ending March 13, 2026, at 1:30 PM EST.

This is a full and open competition with no set-aside designations, and no incumbent contractor information is identified in the solicitation documents. The maximum total contract value is $8,500,000 inclusive of a base year (May 1, 2026 through April 30, 2027) and four option years, with an estimated five-year total value of $6,656,381.33. The estimated Base Year medication total is $1,261,276.27 with an additional $70,000.00 for fees and supplies. The contract will cover multiple VA Medical Centers across Indiana, Ohio, and Michigan, with place of performance at 810 Vermont Ave NW, Washington, DC 20571. No minimum order value is guaranteed; individual task orders will be funded as needs arise, and the NAICS code is 621999 (All Other Miscellaneous Ambulatory Health Care Services) with a small business size standard of $20.5 Million.